Guardian Pharmacy Services (GRDN) 44th Annual J.P. Morgan Healthcare Conference summary

Business Overview, Market Positioning, and Leadership

• Focuses on long-term care pharmacy services for assisted living and memory care facilities, the fastest-growing segment with a $7 billion drug spend and over 1 million residents nationwide.

• Holds a 13% national market share, serving approximately 140,000 ALF residents and about 204,000 total residents across 54 locations, with significant room for expansion.

• Differentiates through technology, clinical oversight, and comprehensive medication management, addressing unique challenges in assisted living settings.

• Competitive advantages include national scale, data analytics, a co-founder-led management team with deep healthcare and technology experience, and strong alignment to shareholders.

• Faces a fragmented competitive landscape with high barriers to entry due to regulatory, capital, and operational complexity.

Growth Strategy and Financial Performance

• Pursues a multi-pronged growth strategy: organic expansion, disciplined M&A, and contiguous greenfield startups, with a target pool of about 100 acquisition candidates.

• M&A targets independent pharmacies with $10–30 million in revenue, integrating them through operational improvements and national account implementation.

• Consistent top-line growth with a ~16% CAGR from 2012–2025, reaching $1.44 billion projected revenue in 2025.

• Adjusted EBITDA projected at $104–$106 million in 2025 and $115–$118 million in 2026, with margins improving to over 8%.

• Maintains strong margins and cash flow, with a 60% cash conversion rate after CapEx and taxes, and virtually zero debt.

Technology, Service, and Operational Excellence

• Proprietary analytics platforms (Guardian Compass and Guardian Shield) drive internal KPIs and provide data-driven value to partners.

• Over 112,000 pharmacist interventions in 2024 and $41 million in resident savings through formulary optimization.

• Ongoing investments in automation, robotics, and EMR systems enhance safety, efficiency, and compliance for facility partners.

• Service model includes comprehensive drug regimen reviews, compliance packaging, and nurse-led training for facilities.

• Service-led, tech-enabled model with local service and centralized support drives high adoption and a defensible market position.